INNOCAN PHARMA CORPORATION

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

2 filing records in this dataset, filed from 2025-07-23 to 2026-03-16. Explore the available filing history and original sources.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-16; this is not a statement that none were filed.

See all insider transactions

Registration statement

This company has filed to register securities with the SEC and has not yet filed an annual or quarterly report. Its financial statements are in the filing itself rather than structured data, so reported figures appear here once periodic reports are filed.

Offering terms · F-1 · 2026-03-16

Security
Units consisting of: (i) Ordinary shares, no par value (ii) Common Warrants to purchase ordinary shares
Maximum offering price
USD 25,875,000
Registration fee
USD 3,573.34 · 0.0138%
Security
Pre-Funded Units consisting of: (i) Pre-Funded Warrants to purchase ordinary shares (ii) Common Warrants to purchase ordinary shares
Maximum offering price
USD 0
Registration fee
USD 0 · 0.0138%
Security
Representative's Warrants
Maximum offering price
USD 0
Registration fee
USD 0 · 0.0138%
Security
Ordinary shares issuable upon exercise of the common warrants
Maximum offering price
USD 32,343,750
Registration fee
USD 4,466.67 · 0.0138%
Security
Ordinary shares issuable upon exercise of the pre-funded warrants
Maximum offering price
USD 0
Registration fee
USD 0 · 0.0138%
Security
Ordinary shares issuable upon exercise of the Representative's Warrants
Maximum offering price
USD 1,617,187.5
Registration fee
USD 223.33 · 0.0138%

Offering terms · F-1 · 2025-07-23

Security
Units consisting of:
Maximum offering price
USD 17,250,000
Registration fee
USD 2,640.98 · 0.0153%
Security
(i) Common shares, no par value
Maximum offering price
USD 0
Registration fee
USD 0 · 0.0153%
Security
(ii) Common Warrants to purchase common shares
Maximum offering price
USD 0
Registration fee
USD 0 · 0.0153%
Security
Representative's Warrants
Maximum offering price
USD 0
Registration fee
USD 0 · 0.0153%
Security
Common shares issuable upon exercise of the common warrants
Maximum offering price
USD 21,562,500
Registration fee
USD 3,301.22 · 0.0153%
Security
Ordinary shares issuable upon exercise of the Representative's Warrants
Maximum offering price
USD 1,078,125
Registration fee
USD 165.1 · 0.0153%

The maximum offering price is the amount the registration fee is computed on, not what the company expects to raise. The offering size and price range are in the prospectus.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

2 filings · 0 latest values · 0 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001889791, 1889791, edgar:1889791

Also known as INNOCAN PHARMA CORPORATION, INNOCAN PHARMA Corp